News
‘Astonishing’ results: Skip salvage chemo, proceed to HSCT
- Author:
- Neil Osterweil
New research on treating acute myeloid leukemia suggested that some patients may safely go straight to stem cell transplantation.
News
Oral SERD camizestrant prolongs PFS vs. fulvestrant in breast cancer
- Author:
- Neil Osterweil
The investigational selective estrogen receptor degrader showed efficacy in advanced ER+/HER2– breast cancers, including patients with ESR1...
News
Chemotherapy meets its match against aggressive ER+/HER2– breast cancers
- Author:
- Neil Osterweil
Ribociclib plus endocrine therapy resulted in high response rates and double progression-free survival over combo chemotherapy.
News
Potential cause of worse outcomes among Black breast cancer patients found
- Author:
- Neil Osterweil
Tumor microenvironment of metastasis doorways predicted worse outcomes in Black women with residual ER+/HER2– cancer after neoadjuvant...
News
ASH 2022: New clinical data challenge long-held assumptions
- Author:
- Neil Osterweil
Fresh research to be unveiled at the 2022 American Society of Hematology conference seems to overturn conventional wisdom across a range of issues...
News
Poor NAFLD outcomes with increased VCTE-measured liver stiffness
- Author:
- Neil Osterweil
The findings show that “progression to LSM-defined cirrhosis by VCTE is strongly associated with poor clinical outcomes.”
News
New ACR vaccination guideline: Take your best shot
- Author:
- Neil Osterweil
Vaccinate patients with rheumatic and musculoskeletal disease against flu and other vaccine-preventable disease whenever possible, experts say.
News
Midodrine may be comparable to albumin for PICD prevention in ACLF
- Author:
- Neil Osterweil
Given the small size of the open-label study, with only 25 patients in each arm, the results should be considered as proof of concept and need to...
News
Randomized trial finds community-based weight-loss programs ease knee OA pain
- Author:
- Neil Osterweil
Participants who dieted and exercised in a community-based randomized trial had reductions in knee pain at 18 months; controls also improved...
News
Opioids increase risk for all-cause deaths in RA vs. NSAIDs
- Author:
- Neil Osterweil
The incidence of all-cause mortality was higher for patients with rheumatoid arthritis who started on opioids rather than NSAIDs for pain control...
News
Prednisone, colchicine equivalent in efficacy for CPP crystal arthritis
- Author:
- Neil Osterweil
In an open-label, randomized trial, one in five patients on colchicine had diarrhea, tipping the safety scales in favor of prednisone.
News
Steroids and G-CSF improve 90-day survival in severe alcoholic hepatitis
- Author:
- Neil Osterweil
In addition to its superior results on the primary endpoint of 90-day survival, combination therapy was associated with significantly better...
News
Retention rates high after biosimilar-to-biosimilar switch for inflammatory arthritis
- Author:
- Neil Osterweil
Danish investigators studied how a government-mandated switch from one infliximab biosimilar to another affected patients with inflammatory...
News
First recommendations for cancer screening in myositis issued
- Author:
- Neil Osterweil
The guideline, based on data from a systematic review and meta-analysis and on consensus from an international team of experts and patients,...
News
World falls short on HBV, HCV elimination targets
- Author:
- Neil Osterweil
“As countries progress toward eliminating hepatitis B and C, we really need to do more to expand political will and financing of national...